| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020768083 |
| P356 | DOI | 10.1080/13550280390195298 |
| P8608 | Fatcat ID | release_jj6eqny7jbcjndgeli7ftcbd5u |
| P698 | PubMed publication ID | 12709878 |
| P2093 | author name string | Paola Cinque | |
| David B. Clifford | |||
| Igor J. Koralnik | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. | Q33502327 | ||
| Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy | Q33732964 | ||
| Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
| PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE. | Q34260261 | ||
| Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease | Q34538727 | ||
| Neuropathologic complications of infection with the human immunodeficiency virus (HIV). | Q38218831 | ||
| Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy | Q39447387 | ||
| Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring | Q43716024 | ||
| Relapsing and remitting leukoencephalopathy associated with chronic HIV infection | Q43933020 | ||
| A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. | Q44129718 | ||
| Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. | Q44431490 | ||
| The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. | Q45740735 | ||
| Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response | Q45745304 | ||
| Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal study | Q45746860 | ||
| Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. | Q45747990 | ||
| Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy | Q45749053 | ||
| Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients | Q45755978 | ||
| Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis. | Q45757390 | ||
| HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy | Q47727845 | ||
| The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients | Q48539449 | ||
| Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. | Q48789449 | ||
| Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. | Q48889174 | ||
| Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy | Q49024583 | ||
| Progressive multifocal leukoencephalopathy: A burnt-out case | Q53966874 | ||
| Electron microscopic observations on a case of progressive multifocal leukoencephalopathy | Q56430857 | ||
| Diagnosis of central nervous system complications in HIV-infected patients | Q58292184 | ||
| The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS | Q58794493 | ||
| Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors | Q63322067 | ||
| Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy | Q77336908 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
| neurology | Q83042 | ||
| P304 | page(s) | 88-92 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology | |
| The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology | |||
| P478 | volume | 9 Suppl 1 |
| Q30351230 | AIDS-associated progressive multifocal leukoencephalopathy : current management strategies. |
| Q35112030 | Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. |
| Q45723886 | Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment |
| Q37066982 | Antiretroviral therapy and central nervous system HIV type 1 infection |
| Q38368086 | Aspartoacylase deficiency in the white matter of human immunodeficiency virus encephalitis: novel mechanism in axonal damage |
| Q80161248 | Case 15: when a stroke is not a stroke |
| Q81408225 | Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses |
| Q34802752 | Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy |
| Q42251011 | Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. |
| Q35012056 | Determinants of survival in progressive multifocal leukoencephalopathy |
| Q80831430 | Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy |
| Q39244813 | Effects of Tat proteins and Tat mutants of different human immunodeficiency virus type 1 clades on glial JC virus early and late gene transcription |
| Q35785136 | Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy |
| Q33650105 | Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer |
| Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
| Q31031123 | HIV and the central nervous system |
| Q55432495 | HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment. |
| Q92720553 | HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease |
| Q37671117 | Human polyoma viruses and disease with emphasis on clinical BK and JC. |
| Q39877627 | Identification and characterization of mefloquine efficacy against JC virus in vitro |
| Q28478894 | Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy |
| Q35583773 | Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy |
| Q40909757 | Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection |
| Q45357877 | JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome |
| Q37157144 | JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy |
| Q36890313 | Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. |
| Q35609239 | Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. |
| Q36233526 | Management of infections by the human polyomavirus JC: past, present and future |
| Q36198630 | Metabolic profile of PML lesions in patients with and without IRIS: an observational study |
| Q28555138 | Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry |
| Q38221343 | Natalizumab: risk stratification of individual patients with multiple sclerosis |
| Q31111043 | Neuropsychological and neuroimaging outcome of HIV-associated progressive multifocal leukoencephalopathy in the era of antiretroviral therapy |
| Q30352753 | New trends in progressive multifocal leukoencephalopathy |
| Q30613846 | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section |
| Q85157571 | Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient |
| Q37156649 | Progressive multifocal leucoencephalopathy in HIV/AIDS: observational study from a tertiary care centre in northern India |
| Q30631186 | Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C--is not uncommon |
| Q33383576 | Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project |
| Q33893285 | Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis |
| Q64264718 | Progressive multifocal leukoencephalopathy diagnosed by brain biopsy, not by the DNA test for JC Virus |
| Q33506561 | Progressive multifocal leukoencephalopathy in HIV-1 infection |
| Q30778800 | Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review |
| Q42280105 | Progressive multifocal leukoencephalopathy with gastrointestinal disease in a pediatric kidney transplant recipient. |
| Q37755922 | Progressive multifocal leukoencephalopathy: what's new? |
| Q90003732 | Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report |
| Q34178250 | Rearranged JC Virus Noncoding Control Regions Found in Progressive Multifocal Leukoencephalopathy Patient Samples Increase Virus Early Gene Expression and Replication Rate |
| Q34041795 | Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy |
| Q41906877 | Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome |
| Q33789032 | Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy |
| Q39855918 | SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. |
| Q57435818 | SUDS, LID, BMPs, WSUD and more – The evolution and application of terminology surrounding urban drainage |
| Q38115572 | The human JC polyomavirus (JCPyV): virological background and clinical implications |
| Q80028671 | [Correlation between clinical apparatus-based differential diagnosis and neuropathological diagnosis in patients with AIDS] |
Search more.